US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 6.880
  • +0.540+8.52%
Close Dec 20 16:00 ET
  • 6.540
  • -0.340-4.94%
Post 20:01 ET
324.84MMarket Cap-4.10P/E (TTM)

Silence Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-303.45%-19.66M
67.81%-4.81M
2.10%-7.5M
13.43%-39.35M
11.50%-11.87M
48.19%-4.87M
-80.89%-14.96M
46.74%-7.66M
-767.88%-45.46M
-508.07%-13.41M
Net income from continuing operations
-182.88%-30.16M
-45.22%-17.44M
73.45%-3.37M
-6.21%-50.31M
0.56%-14.97M
-14.31%-10.66M
10.51%-12.01M
-32.40%-12.67M
-3.30%-47.37M
-34.05%-15.05M
Operating gains losses
-223.66%-737K
-93.91%19K
58.33%133K
202.52%2.16M
23.80%1.17M
363.72%596K
368.97%312K
-26.32%84K
133.77%713K
77.21%941K
Depreciation and amortization
-8.00%115K
0.85%119K
-10.45%120K
3.32%498K
-14.18%121K
9.65%125K
3.51%118K
18.58%134K
12.88%482K
113.64%141K
Other non cash items
473.95%7.62M
-259.49%-882K
-250.95%-791K
155.50%706K
-59.10%1.67M
52.92%-2.04M
182.66%553K
249.71%524K
-3,128.57%-1.27M
11,422.22%4.08M
Change In working capital
-86.62%491K
246.91%10.18M
-115.55%-15.68M
-41.14%-11.66M
78.38%-1.13M
86.16%3.67M
-350.83%-6.93M
6.24%-7.27M
-121.27%-8.26M
-179.18%-5.24M
-Change in receivables
-88.86%1.15M
155.76%6.19M
-918.88%-8.2M
-34.25%-1.46M
108.94%115K
273.08%10.34M
-3,296.33%-11.11M
64.11%-805K
-103.95%-1.09M
29.40%-1.29M
-Change in payables and accrued expense
-806.38%-664K
478.14%4.64M
-605.01%-2.12M
-96.96%44K
132.86%757K
-96.89%94K
-132.03%-1.23M
113.52%419K
-39.83%1.45M
-269.29%-2.3M
-Change in other current assets
110.94%498K
-217.23%-1.89M
-173.46%-999K
53.37%-1.97M
-165.55%-392K
-124.63%-4.55M
176.41%1.61M
298.25%1.36M
-818.54%-4.23M
122.66%598K
-Change in other working capital
77.60%-495K
-67.29%1.24M
47.15%-4.36M
-88.18%-8.28M
28.25%-1.61M
-23.12%-2.21M
176.31%3.79M
-377.20%-8.25M
-152.56%-4.4M
-123.13%-2.25M
Cash from discontinued investing activities
Operating cash flow
-303.45%-19.66M
67.81%-4.81M
2.10%-7.5M
13.43%-39.35M
11.50%-11.87M
48.19%-4.87M
-80.89%-14.96M
46.74%-7.66M
-767.88%-45.46M
-508.07%-13.41M
Investing cash flow
Cash flow from continuing investing activities
-239.81%-28.84M
111.64%548K
-30,593.75%-39.03M
199.32%16.43M
102.33%382K
49,214.29%20.63M
-13,351.43%-4.71M
350.98%128K
-290.66%-16.54M
-468.69%-16.41M
Net PPE purchase and sale
-145.00%-49K
-2,333.33%-67K
--0
67.86%-45K
66.67%-1K
57.45%-20K
103.33%3K
---27K
89.32%-140K
99.43%-3K
Net intangibles purchase and sale
----
----
--0
--0
----
----
----
---6K
-1,204.35%-300K
----
Net investment purchase and sale
-245.52%-29.25M
--0
---39.44M
196.23%15.52M
--0
--20.1M
-229,150.00%-4.59M
--0
-261.25%-16.13M
-422.50%-16.13M
Cash from discontinued investing activities
Investing cash flow
-239.81%-28.84M
111.64%548K
-30,593.75%-39.03M
199.32%16.43M
102.33%382K
49,214.29%20.63M
-13,351.43%-4.71M
350.98%128K
-290.66%-16.54M
-468.69%-16.41M
Financing cash flow
Cash flow from continuing financing activities
-50.40%5.97M
-73.40%847K
555,500.00%105.56M
-41.57%25.16M
22,445.45%9.92M
-72.06%12.03M
29,045.45%3.18M
140.43%19K
40.17%43.05M
44K
Net issuance payments of debt
0.00%-49K
-185.29%-97K
--0
8.42%-174K
44.87%-43K
-226.67%-49K
32.00%-34K
-2.13%-48K
9.95%-190K
-7,700.00%-78K
Net common stock issuance
-50.31%6.34M
-70.67%944K
167,226.87%112.11M
-41.42%25.33M
7,512.30%9.29M
-70.39%12.76M
8,151.28%3.22M
--67K
39.83%43.24M
12,100.00%122K
Net other financing activities
---322K
--0
---6.55M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-50.40%5.97M
-73.40%847K
555,500.00%105.56M
-41.57%25.16M
22,445.45%9.92M
-72.06%12.03M
29,045.45%3.18M
140.43%19K
40.17%43.05M
--44K
Net cash flow
Beginning cash position
268.38%109.48M
141.93%113.06M
-1.43%54.03M
-25.46%54.82M
-34.67%58.81M
-42.36%29.72M
-21.19%46.73M
-25.46%54.82M
167.90%73.54M
25.95%90.02M
Current changes in cash
-253.05%-42.53M
79.25%-3.42M
886.22%59.04M
111.79%2.24M
94.75%-1.56M
-17.34%27.79M
-98.22%-16.48M
48.12%-7.51M
-141.02%-18.95M
-1,425.23%-29.78M
Effect of exchange rate changes
-483.44%-5M
70.81%-155K
97.92%-12K
-1,424.56%-3.02M
40.68%-3.22M
-73.03%1.3M
-190.92%-531K
-348.28%-576K
317.14%228K
-2,929.61%-5.42M
End cash Position
5.34%61.95M
268.38%109.48M
141.93%113.06M
-1.43%54.03M
-1.43%54.03M
-34.67%58.81M
-42.36%29.72M
-21.19%46.73M
-25.46%54.82M
-25.46%54.82M
Free cash flow
-302.80%-19.71M
67.34%-4.88M
2.52%-7.5M
14.16%-39.4M
13.45%-11.87M
48.24%-4.89M
-78.83%-14.95M
46.52%-7.69M
-938.74%-45.9M
-397.68%-13.71M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -303.45%-19.66M67.81%-4.81M2.10%-7.5M13.43%-39.35M11.50%-11.87M48.19%-4.87M-80.89%-14.96M46.74%-7.66M-767.88%-45.46M-508.07%-13.41M
Net income from continuing operations -182.88%-30.16M-45.22%-17.44M73.45%-3.37M-6.21%-50.31M0.56%-14.97M-14.31%-10.66M10.51%-12.01M-32.40%-12.67M-3.30%-47.37M-34.05%-15.05M
Operating gains losses -223.66%-737K-93.91%19K58.33%133K202.52%2.16M23.80%1.17M363.72%596K368.97%312K-26.32%84K133.77%713K77.21%941K
Depreciation and amortization -8.00%115K0.85%119K-10.45%120K3.32%498K-14.18%121K9.65%125K3.51%118K18.58%134K12.88%482K113.64%141K
Other non cash items 473.95%7.62M-259.49%-882K-250.95%-791K155.50%706K-59.10%1.67M52.92%-2.04M182.66%553K249.71%524K-3,128.57%-1.27M11,422.22%4.08M
Change In working capital -86.62%491K246.91%10.18M-115.55%-15.68M-41.14%-11.66M78.38%-1.13M86.16%3.67M-350.83%-6.93M6.24%-7.27M-121.27%-8.26M-179.18%-5.24M
-Change in receivables -88.86%1.15M155.76%6.19M-918.88%-8.2M-34.25%-1.46M108.94%115K273.08%10.34M-3,296.33%-11.11M64.11%-805K-103.95%-1.09M29.40%-1.29M
-Change in payables and accrued expense -806.38%-664K478.14%4.64M-605.01%-2.12M-96.96%44K132.86%757K-96.89%94K-132.03%-1.23M113.52%419K-39.83%1.45M-269.29%-2.3M
-Change in other current assets 110.94%498K-217.23%-1.89M-173.46%-999K53.37%-1.97M-165.55%-392K-124.63%-4.55M176.41%1.61M298.25%1.36M-818.54%-4.23M122.66%598K
-Change in other working capital 77.60%-495K-67.29%1.24M47.15%-4.36M-88.18%-8.28M28.25%-1.61M-23.12%-2.21M176.31%3.79M-377.20%-8.25M-152.56%-4.4M-123.13%-2.25M
Cash from discontinued investing activities
Operating cash flow -303.45%-19.66M67.81%-4.81M2.10%-7.5M13.43%-39.35M11.50%-11.87M48.19%-4.87M-80.89%-14.96M46.74%-7.66M-767.88%-45.46M-508.07%-13.41M
Investing cash flow
Cash flow from continuing investing activities -239.81%-28.84M111.64%548K-30,593.75%-39.03M199.32%16.43M102.33%382K49,214.29%20.63M-13,351.43%-4.71M350.98%128K-290.66%-16.54M-468.69%-16.41M
Net PPE purchase and sale -145.00%-49K-2,333.33%-67K--067.86%-45K66.67%-1K57.45%-20K103.33%3K---27K89.32%-140K99.43%-3K
Net intangibles purchase and sale ----------0--0---------------6K-1,204.35%-300K----
Net investment purchase and sale -245.52%-29.25M--0---39.44M196.23%15.52M--0--20.1M-229,150.00%-4.59M--0-261.25%-16.13M-422.50%-16.13M
Cash from discontinued investing activities
Investing cash flow -239.81%-28.84M111.64%548K-30,593.75%-39.03M199.32%16.43M102.33%382K49,214.29%20.63M-13,351.43%-4.71M350.98%128K-290.66%-16.54M-468.69%-16.41M
Financing cash flow
Cash flow from continuing financing activities -50.40%5.97M-73.40%847K555,500.00%105.56M-41.57%25.16M22,445.45%9.92M-72.06%12.03M29,045.45%3.18M140.43%19K40.17%43.05M44K
Net issuance payments of debt 0.00%-49K-185.29%-97K--08.42%-174K44.87%-43K-226.67%-49K32.00%-34K-2.13%-48K9.95%-190K-7,700.00%-78K
Net common stock issuance -50.31%6.34M-70.67%944K167,226.87%112.11M-41.42%25.33M7,512.30%9.29M-70.39%12.76M8,151.28%3.22M--67K39.83%43.24M12,100.00%122K
Net other financing activities ---322K--0---6.55M----------------------------
Cash from discontinued financing activities
Financing cash flow -50.40%5.97M-73.40%847K555,500.00%105.56M-41.57%25.16M22,445.45%9.92M-72.06%12.03M29,045.45%3.18M140.43%19K40.17%43.05M--44K
Net cash flow
Beginning cash position 268.38%109.48M141.93%113.06M-1.43%54.03M-25.46%54.82M-34.67%58.81M-42.36%29.72M-21.19%46.73M-25.46%54.82M167.90%73.54M25.95%90.02M
Current changes in cash -253.05%-42.53M79.25%-3.42M886.22%59.04M111.79%2.24M94.75%-1.56M-17.34%27.79M-98.22%-16.48M48.12%-7.51M-141.02%-18.95M-1,425.23%-29.78M
Effect of exchange rate changes -483.44%-5M70.81%-155K97.92%-12K-1,424.56%-3.02M40.68%-3.22M-73.03%1.3M-190.92%-531K-348.28%-576K317.14%228K-2,929.61%-5.42M
End cash Position 5.34%61.95M268.38%109.48M141.93%113.06M-1.43%54.03M-1.43%54.03M-34.67%58.81M-42.36%29.72M-21.19%46.73M-25.46%54.82M-25.46%54.82M
Free cash flow -302.80%-19.71M67.34%-4.88M2.52%-7.5M14.16%-39.4M13.45%-11.87M48.24%-4.89M-78.83%-14.95M46.52%-7.69M-938.74%-45.9M-397.68%-13.71M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data